Loading...
Recombinant human erythropoietin inhibits iNOS activity and reverts vascular dysfunction in splanchnic artery occlusion shock
1. We investigated the effects of recombinant human erythropoietin (rh-EPO) in splanchnic artery occlusion (SAO) shock. Sham operated animals were used as controls. Survival rate, mean arterial blood pressure (MAP), serum Tumor Necrosis Factor (TNF-α), plasma nitrite/nitrate concentrations, red bloo...
Na minha lista:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
1999
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1566014/ https://ncbi.nlm.nih.gov/pubmed/10385249 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjp.0702521 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|